Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:54 PM
Ignite Modification Date:
2025-12-24 @ 4:54 PM
NCT ID:
NCT00000850
Eligibility Criteria:
Inclusion Criteria
Patients may be eligible for this study if they:
* Are HIV-positive.
* Have a stable viral load of at least 1,500 copies/ml within 30 days of study entry.
* Are on stable aggressive anti-HIV therapy for at least 8 weeks before study entry and intend to remain on this therapy during the study.
* Agree to learn how to give themselves the GM-CSF shots.
* Agree to practice acceptable barrier methods of birth control (such as condoms) during the study and for at least 12 weeks after treatment ends.
* Are at least 18 years old.
Exclusion Criteria
Patients will not be eligible for this study if they:
* Have an infection or other illness within 14 days of study entry.
* Have certain types of hepatitis within 30 days of study entry.
* Have a fever or chronic diarrhea within 30 days of study entry.
* Have cancer (except for certain types of Kaposi's sarcoma).
* Have heart disease.
* Are allergic to GM-CSF.
* Have received certain medications.
* Are pregnant or breast-feeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00000850
Study Brief:
Protocol Section:
NCT00000850